<VariationArchive RecordType="classified" VariationID="817772" VariationName="NM_006516.4(SLC2A1):c.1077_1083del (p.Glu359fs)" VariationType="Deletion" Accession="VCV000817772" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2020-03-16" MostRecentSubmission="2020-03-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="806275" VariationID="817772">
      <GeneList>
        <Gene Symbol="SLC2A1" FullName="solute carrier family 2 member 1" GeneID="6513" HGNC_ID="HGNC:11005" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p34.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42925353" stop="42958868" display_start="42925353" display_stop="42958868" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="43391045" stop="43424846" display_start="43391045" display_stop="43424846" Strand="-" />
          </Location>
          <OMIM>138140</OMIM>
          <Haploinsufficiency last_evaluated="2016-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC2A1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2016-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC2A1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006516.4(SLC2A1):c.1077_1083del (p.Glu359fs)</Name>
      <CanonicalSPDI>NC_000001.11:42927799:TAGCTGCT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p34.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42927800" stop="42927806" display_start="42927800" display_stop="42927806" variantLength="7" positionVCF="42927799" referenceAlleleVCF="GTAGCTGC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="43393471" stop="43393477" display_start="43393471" display_stop="43393477" variantLength="7" positionVCF="43393470" referenceAlleleVCF="GTAGCTGC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>E359fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.43393472_43393478del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.43393472_43393478del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.42927801_42927807del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.42927801_42927807del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008232.1" sequenceAccession="NG_008232" sequenceVersion="1" change="g.36371_36377del">
            <Expression>NG_008232.1:g.36371_36377del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006516.4" sequenceAccession="NM_006516" sequenceVersion="4" change="c.1077_1083del" MANESelect="true">
            <Expression>NM_006516.4:c.1077_1083del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006507.2" sequenceAccession="NP_006507" sequenceVersion="2" change="p.Glu359fs">
            <Expression>NP_006507.2:p.Glu359fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1132" sequenceAccession="LRG_1132">
            <Expression>LRG_1132:g.36371_36377del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1570591037" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006516.4(SLC2A1):c.1077_1083del (p.Glu359fs) AND not provided" Accession="RCV001008987" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-08-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-08-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-03-16" MostRecentSubmission="2020-03-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2306788" SubmissionDate="2019-10-15" DateLastUpdated="2020-03-16" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="GDX:2344597|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001168795" DateUpdated="2020-03-16" DateCreated="2020-03-16" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-08-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1077_1083delGCAGCTA pathogenic variant in the SLC2A1 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The c.1077_1083delGCAGCTA variant causes a frameshift starting with codon Glutamic acid 359, changes this amino acid to a Aspartic acid residue, and creates a premature Stop codon at position 7 of the new reading frame, denoted p.Glu359AspfsX7. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.1077_1083delGCAGCTA variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.1077_1083delGCAGCTA as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC2A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006516.2:c.1077_1083delGCAGCTA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6425168</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2306788" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

